397 related articles for article (PubMed ID: 30983433)
41. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
Kubala JM; Laursen KB; Schreiner R; Williams RM; van der Mijn JC; Crowley MJ; Mongan NP; Nanus DM; Heller DA; Gudas LJ
Cancer Biol Ther; 2023 Dec; 24(1):2170669. PubMed ID: 36722045
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
43. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
44. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
45. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
[TBL] [Abstract][Full Text] [Related]
46. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
[TBL] [Abstract][Full Text] [Related]
47. Metabolomics activity screening for identifying metabolites that modulate phenotype.
Guijas C; Montenegro-Burke JR; Warth B; Spilker ME; Siuzdak G
Nat Biotechnol; 2018 Apr; 36(4):316-320. PubMed ID: 29621222
[TBL] [Abstract][Full Text] [Related]
48. Exploring serum metabolic markers for the discrimination of ccRCC from renal angiomyolipoma by metabolomics.
Xiang M; Du F; Dai J; Chen L; Geng R; Huang H; Xie B
Biomark Med; 2020 Jun; 14(8):675-682. PubMed ID: 32613842
[No Abstract] [Full Text] [Related]
49. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.
di Meo NA; Lasorsa F; Rutigliano M; Milella M; Ferro M; Battaglia M; Ditonno P; Lucarelli G
Expert Rev Mol Diagn; 2023 Apr; 23(4):297-313. PubMed ID: 36960789
[TBL] [Abstract][Full Text] [Related]
50. Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation.
Liu J; Hanavan PD; Kras K; Ruiz YW; Castle EP; Lake DF; Chen X; O'Brien D; Luo H; Robertson KD; Gu H; Ho TH
J Proteome Res; 2019 Jan; 18(1):331-340. PubMed ID: 30406665
[TBL] [Abstract][Full Text] [Related]
51. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
52. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
[TBL] [Abstract][Full Text] [Related]
53. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
54. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
55. SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis.
Ma Y; Qi Y; Wang L; Zheng Z; Zhang Y; Zheng J
Free Radic Biol Med; 2019 Apr; 134():458-467. PubMed ID: 30703481
[TBL] [Abstract][Full Text] [Related]
56. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
[TBL] [Abstract][Full Text] [Related]
57. Causal integration of multi-omics data with prior knowledge to generate mechanistic hypotheses.
Dugourd A; Kuppe C; Sciacovelli M; Gjerga E; Gabor A; Emdal KB; Vieira V; Bekker-Jensen DB; Kranz J; Bindels EMJ; Costa ASH; Sousa A; Beltrao P; Rocha M; Olsen JV; Frezza C; Kramann R; Saez-Rodriguez J
Mol Syst Biol; 2021 Jan; 17(1):e9730. PubMed ID: 33502086
[TBL] [Abstract][Full Text] [Related]
58. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
[TBL] [Abstract][Full Text] [Related]
59. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
60. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
